<p>Wedge Capital Management L L P NC 在最近向美國證券交易委員會提交的 13F 表格中披露，在第三季度收購了 Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 免費報告）的新股份。該基金收購了 138,228 股公司股票，價值約為 2,315,000 美元。Wedge Capital Management L L P NC 在最近一個季度末持有 Pediatrix Medical Group 0.16% 的股份。</p>
<ul>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
</ul>
<p>其他幾家機構投資者和對沖基金最近也調整了對 MD 的持股。Voya Investment Management LLC 在第三季度將其在 Pediatrix Medical Group 的股份增加了 62.4%。Voya Investment Management LLC 目前持有 39,132 股公司股票，價值 655,000 美元，在此期間又購買了 15,030 股。Squarepoint Ops LLC 在第二季度將其在 Pediatrix Medical Group 的股份增加了 234.6%。Squarepoint Ops LLC 目前持有 81,142 股公司股票，價值 1,164,000 美元，在上個季度又收購了 56,889 股。野村控股公司在第二季度將其在 Pediatrix Medical Group 的持股增加了 121.4%。野村控股公司目前持有 576,730 股公司股票，價值 8,276,000 美元，在此期間又收購了 316,274 股。Caxton Associates LLP 在第二季度購買了 Pediatrix Medical Group 的新股份，價值約為 236,000 美元。最後，公共部門養老金投資委員會在第二季度將其在 Pediatrix Medical Group 的股份增加了 7.1%。公共部門養老金投資委員會目前持有 287,060 股公司股票，價值 4,119,000 美元，在上個季度又收購了 18,984 股。97.71% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>華爾街分析師預測增長</h2>
<p>幾位股票研究分析師最近對 MD 股票發表了看法。華爾街 Zen 在 10 月 4 日的研究報告中將 Pediatrix Medical Group 的評級從 “買入” 上調至 “強力買入”。Truist Financial 在 11 月 10 日的研究報告中將 Pediatrix Medical Group 的目標股價從 17.00 美元提高至 24.00 美元，並給予該股票 “持有” 評級。Zacks Research 在 11 月 21 日的研究報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。Leerink Partners 在 9 月 5 日的報告中將 Pediatrix Medical Group 的目標股價從 14.50 美元提高至 17.00 美元，並給予該股票 “市場表現” 評級。最後，Weiss Ratings 在週一的研究報告中重申了對 Pediatrix Medical Group 的 “持有（c+）” 評級。一位投資分析師對該股票給予了強力買入評級，一位給予了買入評級，四位給予了持有評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，平均目標價為 21.00 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p><strong>閲讀我們關於 Pediatrix Medical Group 的最新報告</strong></p>
<h2>內部人士下注</h2>
<p>在其他 Pediatrix Medical Group 的新聞中，董事 Michael A. Rucker 於 11 月 17 日星期一出售了 10,478 股 Pediatrix Medical Group 股票。股票以平均價格 23.00 美元出售，總價值為 240,994.00 美元。出售完成後，該董事持有 59,101 股公司股票，價值約為 1,359,323 美元。此次交易使其持股減少了 15.06%。該交易已在向美國證券交易委員會提交的文件中披露，您可以通過此超鏈接訪問。此外，首席執行官 Mark S. Ordan 於 12 月 15 日星期一出售了 23,000 股該股票。股票以平均價格 22.41 美元出售，總價值為 515,430.00 美元。交易完成後，首席執行官直接持有 302,805 股公司股票，價值 6,785,860.05 美元。此次交易使其持股減少了 7.06%。該銷售的 SEC 文件提供了更多信息。在上個季度，內部人士出售了價值 972,924 美元的 43,478 股公司股票。公司內部人士持有 0.90% 的公司股票。</p>
<h2>Pediatrix Medical Group 股票下跌 2.5%</h2>
<ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
<p>紐約證券交易所：MD 週三開盤價為 21.45 美元。該公司的市值為 18.4 億美元，市盈率為 11.29，貝塔值為 0.77。該公司的債務與股本比率為 0.65，速動比率為 1.83，流動比率為 1.83。Pediatrix Medical Group, Inc. 的 52 周低點為 11.84 美元，52 周高點為 24.99 美元。該公司的 50 日簡單移動平均為 21.18 美元，200 日簡單移動平均為 17.17 美元。</p>
<p>Pediatrix Medical Group（紐約證券交易所：MD - 獲取免費報告）最近於 11 月 3 日星期一發布了其財報。該公司報告本季度每股收益（EPS）為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。該公司本季度的收入為 4.9288 億美元，而市場共識預期為 4.7645 億美元。Pediatrix Medical Group 的淨利潤率為 8.44%，股本回報率為 20.45%。該公司的收入同比下降了 3.6%。在去年同期，該公司每股收益為 0.44 美元。分析師預測 Pediatrix Medical Group, Inc. 本財年將發佈 1.38 美元的每股收益。</p>
<h2>Pediatrix Medical Group 簡介</h2>
<p>（免費報告）</p>
<p>Pediatrix Medical Group, Inc NYSE: MD 是一家全國性的由醫生主導的醫療集團，專注於高危新生兒、母胎及兒科專業護理。公司總部位於佛羅里達州的陽光城，通過醫院基礎的醫生配備、高級從業者支持和遠程醫療項目提供臨牀服務。其核心專業包括新生兒醫學、母胎醫學、兒科心臟病學、兒科重症監護、兒科急救醫學和麻醉學。</p>
<p>公司成立於 1979 年，前身為 MEDNAX，2022 年更名為 Pediatrix Medical Group，以使其企業形象與主要臨牀服務相一致。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Pediatrix Medical Group</li>
<li>持續帶來收益的禮物（今天只需 1 美元）</li>
<li>這個假期你花的最值得的 1 美元</li>
<li>特朗普做了什麼？？</li>
<li>可能每月帶來 4290 美元收益的無聊 AI 投資</li>
<li>特朗普的 “美國房地產交易” 解讀</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Pediatrix Medical Group 嗎？</h2>
<p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Pediatrix Medical Group 並不在名單上。</p>
<p>雖然 Pediatrix Medical Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Wedge Capital Management L L P NC 收購了 138,228 股 Pediatrix Medical Group，價值 231.5 萬美元。其他機構投資者也增加了他們的持股。分析師對該股票給予了 “適度買入” 的共識評級，目標價格為 21.00 美元。最近的內部銷售包括 43,478 股，價值 972,924 美元。該股票開盤價為 21.45 美元，市值為 18.4 億美元</p>

<p>Wedge Capital Management L L P NC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 138,228 shares of the company's stock, valued at approximately $2,315,000. Wedge Capital Management L L P NC owned 0.16% of Pediatrix Medical Group at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Wedge Capital Management L L P NC 在最近向美國證券交易委員會提交的 13F 表格中披露，在第三季度收購了 Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 免費報告）的新股份。該基金收購了 138,228 股公司股票，價值約為 2,315,000 美元。Wedge Capital Management L L P NC 在最近一個季度末持有 Pediatrix Medical Group 0.16% 的股份。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到立足點——現在正在獲得動能</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also recently modified their holdings of MD. Voya Investment Management LLC increased its position in shares of Pediatrix Medical Group by 62.4% during the third quarter. Voya Investment Management LLC now owns 39,132 shares of the company's stock valued at $655,000 after buying an additional 15,030 shares during the period. Squarepoint Ops LLC boosted its position in Pediatrix Medical Group by 234.6% during the 2nd quarter. Squarepoint Ops LLC now owns 81,142 shares of the company's stock valued at $1,164,000 after acquiring an additional 56,889 shares in the last quarter. Nomura Holdings Inc. grew its holdings in shares of Pediatrix Medical Group by 121.4% during the 2nd quarter. Nomura Holdings Inc. now owns 576,730 shares of the company's stock worth $8,276,000 after acquiring an additional 316,274 shares during the period. Caxton Associates LLP bought a new position in shares of Pediatrix Medical Group in the 2nd quarter worth approximately $236,000. Finally, Public Sector Pension Investment Board raised its position in shares of Pediatrix Medical Group by 7.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 287,060 shares of the company's stock worth $4,119,000 after acquiring an additional 18,984 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金最近也調整了對 MD 的持股。Voya Investment Management LLC 在第三季度將其在 Pediatrix Medical Group 的股份增加了 62.4%。Voya Investment Management LLC 目前持有 39,132 股公司股票，價值 655,000 美元，在此期間又購買了 15,030 股。Squarepoint Ops LLC 在第二季度將其在 Pediatrix Medical Group 的股份增加了 234.6%。Squarepoint Ops LLC 目前持有 81,142 股公司股票，價值 1,164,000 美元，在上個季度又收購了 56,889 股。野村控股公司在第二季度將其在 Pediatrix Medical Group 的持股增加了 121.4%。野村控股公司目前持有 576,730 股公司股票，價值 8,276,000 美元，在此期間又收購了 316,274 股。Caxton Associates LLP 在第二季度購買了 Pediatrix Medical Group 的新股份，價值約為 236,000 美元。最後，公共部門養老金投資委員會在第二季度將其在 Pediatrix Medical Group 的股份增加了 7.1%。公共部門養老金投資委員會目前持有 287,060 股公司股票，價值 4,119,000 美元，在上個季度又收購了 18,984 股。97.71% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several equities research analysts recently weighed in on MD shares. Wall Street Zen raised Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, October 4th. Truist Financial increased their price target on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a &#34;hold&#34; rating in a research note on Monday, November 10th. Zacks Research raised shares of Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, November 21st. Leerink Partners upped their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a &#34;market perform&#34; rating in a report on Friday, September 5th. Finally, Weiss Ratings reaffirmed a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $21.00.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對 MD 股票發表了看法。華爾街 Zen 在 10 月 4 日的研究報告中將 Pediatrix Medical Group 的評級從 “買入” 上調至 “強力買入”。Truist Financial 在 11 月 10 日的研究報告中將 Pediatrix Medical Group 的目標股價從 17.00 美元提高至 24.00 美元，並給予該股票 “持有” 評級。Zacks Research 在 11 月 21 日的研究報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。Leerink Partners 在 9 月 5 日的報告中將 Pediatrix Medical Group 的目標股價從 14.50 美元提高至 17.00 美元，並給予該股票 “市場表現” 評級。最後，Weiss Ratings 在週一的研究報告中重申了對 Pediatrix Medical Group 的 “持有（c+）” 評級。一位投資分析師對該股票給予了強力買入評級，一位給予了買入評級，四位給予了持有評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，平均目標價為 21.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Read Our Latest Report on Pediatrix Medical Group</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Pediatrix Medical Group 的最新報告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of Pediatrix Medical Group stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $23.00, for a total value of $240,994.00. Following the completion of the sale, the director owned 59,101 shares of the company's stock, valued at approximately $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Mark S. Ordan sold 23,000 shares of the stock in a transaction on Monday, December 15th. The shares were sold at an average price of $22.41, for a total value of $515,430.00. Following the transaction, the chief executive officer directly owned 302,805 shares in the company, valued at $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 43,478 shares of company stock valued at $972,924. Company insiders own 0.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Pediatrix Medical Group 的新聞中，董事 Michael A. Rucker 於 11 月 17 日星期一出售了 10,478 股 Pediatrix Medical Group 股票。股票以平均價格 23.00 美元出售，總價值為 240,994.00 美元。出售完成後，該董事持有 59,101 股公司股票，價值約為 1,359,323 美元。此次交易使其持股減少了 15.06%。該交易已在向美國證券交易委員會提交的文件中披露，您可以通過此超鏈接訪問。此外，首席執行官 Mark S. Ordan 於 12 月 15 日星期一出售了 23,000 股該股票。股票以平均價格 22.41 美元出售，總價值為 515,430.00 美元。交易完成後，首席執行官直接持有 302,805 股公司股票，價值 6,785,860.05 美元。此次交易使其持股減少了 7.06%。該銷售的 SEC 文件提供了更多信息。在上個季度，內部人士出售了價值 972,924 美元的 43,478 股公司股票。公司內部人士持有 0.90% 的公司股票。</p>
</div><h2>Pediatrix Medical Group Stock Down 2.5%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 2.5%</h2>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
</div><p>NYSE:MD opened at $21.45 on Wednesday. The firm has a market cap of $1.84 billion, a P/E ratio of 11.29 and a beta of 0.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.83 and a current ratio of 1.83. Pediatrix Medical Group, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $24.99. The firm has a 50-day simple moving average of $21.18 and a two-hundred day simple moving average of $17.17.</p>
<div class="lb-trans"><p>紐約證券交易所：MD 週三開盤價為 21.45 美元。該公司的市值為 18.4 億美元，市盈率為 11.29，貝塔值為 0.77。該公司的債務與股本比率為 0.65，速動比率為 1.83，流動比率為 1.83。Pediatrix Medical Group, Inc. 的 52 周低點為 11.84 美元，52 周高點為 24.99 美元。該公司的 50 日簡單移動平均為 21.18 美元，200 日簡單移動平均為 17.17 美元。</p>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.21. The firm had revenue of $492.88 million for the quarter, compared to the consensus estimate of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The business's revenue was down 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.44 earnings per share. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（紐約證券交易所：MD - 獲取免費報告）最近於 11 月 3 日星期一發布了其財報。該公司報告本季度每股收益（EPS）為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。該公司本季度的收入為 4.9288 億美元，而市場共識預期為 4.7645 億美元。Pediatrix Medical Group 的淨利潤率為 8.44%，股本回報率為 20.45%。該公司的收入同比下降了 3.6%。在去年同期，該公司每股收益為 0.44 美元。分析師預測 Pediatrix Medical Group, Inc. 本財年將發佈 1.38 美元的每股收益。</p>
</div><h2>Pediatrix Medical Group Profile</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc NYSE: MD 是一家全國性的由醫生主導的醫療集團，專注於高危新生兒、母胎及兒科專業護理。公司總部位於佛羅里達州的陽光城，通過醫院基礎的醫生配備、高級從業者支持和遠程醫療項目提供臨牀服務。其核心專業包括新生兒醫學、母胎醫學、兒科心臟病學、兒科重症監護、兒科急救醫學和麻醉學。</p>
</div><p>Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.</p>
<div class="lb-trans"><p>公司成立於 1979 年，前身為 MEDNAX，2022 年更名為 Pediatrix Medical Group，以使其企業形象與主要臨牀服務相一致。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>The gift that keeps giving (just $1 today)</li>
<li>The Best $1 You'll Spend This Holiday Season</li>
<li>Trump Did WHAT??</li>
<li>The boring AI play that could pay up to $4,290 monthly</li>
<li>Trump’s “real estate deal for America” explained</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Pediatrix Medical Group</li>
<li>持續帶來收益的禮物（今天只需 1 美元）</li>
<li>這個假期你花的最值得的 1 美元</li>
<li>特朗普做了什麼？？</li>
<li>可能每月帶來 4290 美元收益的無聊 AI 投資</li>
<li>特朗普的 “美國房地產交易” 解讀</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Pediatrix Medical Group 嗎？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Pediatrix Medical Group 並不在名單上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Pediatrix Medical Group 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Wedge Capital Management L L P NC 購買了 Pediatrix Medical Group, Inc.的新股票 $MD